Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.

NCT06720662 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
294
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Sao Paulo

Collaborators